News

CME Group thrives on market volatility with innovative derivatives, global growth, and strong financials, offering stability, ...
Analysts have set 12-month price targets for CME Group, revealing an average target of $266.18, a high estimate of $305.00, ...
What Happened: Gerdes's decision to sell 4,000 shares of CME Group was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the sale is $1,060,441 ...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...
With an ROA of 0.64%, the company may face hurdles in achieving optimal financial performance. Debt Management: CME Group's debt-to ... Analysts typically rate each stock once per quarter.
In the first quarter of 2025, CME Group reported total revenues of $1,642.3 million, marking a 10% increase from the same ...
DGRO boasts a low expense ratio, strong liquidity, and a healthy dividend yield. See why I think the fund is a buy.
The blueprint is based on Nasdaq's own migration to AWS. Nasdaq began moving its trading platform to AWS in 2022, starting with one of its options exchanges, known as Nasdaq MRX. The stock exchange ...
Q1 2025 Earnings Call Transcript April 23, 2025 CME Group Inc. reports earnings inline with expectations. Reported EPS is ...
Shares of CME Group Inc. Cl A CME rose 1.73% to $277.08 Wednesday, on what proved to be an all-around great trading session ...
UBS analyst Alex Kramm maintained a Buy rating on CME Group (CME – Research Report) yesterday and set a price target of $305.00. The company’s ...